Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Amortization of Deferred Charges: 2009-2014

Historic Amortization of Deferred Charges for Capricor Therapeutics (CAPR) over the last 3 years, with Dec 2014 value amounting to $8.3 million.

  • Capricor Therapeutics' Amortization of Deferred Charges was N/A to -$1.0 million in Q4 2014 from the same period last year, while for Dec 2014 it was $8.3 million, marking a year-over-year change of. This contributed to the annual value of $8.3 million for FY2014, which is N/A change from last year.
  • As of FY2014, Capricor Therapeutics' Amortization of Deferred Charges stood at $8.3 million, which was up 2,273.05% from $351,165 recorded in FY2010.
  • In the past 5 years, Capricor Therapeutics' Amortization of Deferred Charges registered a high of $8.3 million during FY2014, and its lowest value of $351,165 during FY2010.
  • Its 1-year average for Amortization of Deferred Charges is $8.3 million, with a median of $8.3 million in 2014.